Macro Finance
Trump’s Drug-Price Push to Cut Access Outside US, Study Says
Bloomberg Markets·September 13, 2026·1 min read
A study found the Trump administration's push to lower US drug spending incentivizes pharmaceutical companies to raise prices and reduce access in other countries. The research highlights a potential global trade-off as US policy pressures drugmakers to offset revenue losses abroad.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.